These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20090361)

  • 1. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subclinical acute rejections in protocol biopsies at 3 months after kidney transplantation].
    Matl I; Honsová E; Lodererová A; Lánská V; Viklický O
    Vnitr Lek; 2008 Nov; 54(11):1054-8. PubMed ID: 19069678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and chemokine gene expression in human kidney transplantation.
    Hribova P; Kotsch K; Brabcova I; Vitko S; Volk HD; Lacha J
    Transplant Proc; 2005 Mar; 37(2):760-3. PubMed ID: 15848523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of RANTES and MIP-1 alpha in acute rejection episode in kidney transplantation].
    Shi BB; Wang HJ; Ji ZG; Wang JT; Li HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):70-2. PubMed ID: 15052779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
    Karason K; Jernås M; Hägg DA; Svensson PA
    BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
    Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
    Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal cytokine and chemokine gene expression and kidney graft outcome.
    Hribova P; Lacha J; Kotsch K; Volk HD; Brabcova I; Skibova J; Vitko S; Viklicky O
    Kidney Blood Press Res; 2007; 30(5):273-82. PubMed ID: 17622765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we have to treat subclinical rejections in early protocol renal allograft biopsies?
    Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Lekovski Lj; Ivanovski N; Popov Z
    Transplant Proc; 2007 Oct; 39(8):2550-3. PubMed ID: 17954170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation.
    Mao Y; Chen J; Shou Z; Wu J; Wang H; He Q
    Transpl Immunol; 2007 Apr; 17(3):211-4. PubMed ID: 17331849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
    Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
    J Nephrol; 2008; 21(4):535-42. PubMed ID: 18651543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death 1 mRNA in peripheral blood as biomarker of acute renal allograft rejection.
    Wang YW; Wang Z; Shi BY
    Chin Med J (Engl); 2011 Mar; 124(5):674-8. PubMed ID: 21518556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.
    Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M
    Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation.
    Strehlau J; Pavlakis M; Lipman M; Maslinski W; Shapiro M; Strom TB
    Clin Nephrol; 1996 Jul; 46(1):30-3. PubMed ID: 8832147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
    Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
    J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.